Rare diseases
Investigational molecules
Locations
Ul. Luzycka 3c, 81-537 Gdynia, Poland
Synexus Polska Sp. z o.o. in Gdynia, Poland specialises in clinical trials of conditions such as Obesity, Psoriasis, Dermatitis atopic, Metabolic dysfunction-associated steatohepatitis, and other specialisations. This site conducts important research.
The medical center is at the forefront of research in Chronic Obstructive Pulmonary Disease (COPD), focusing on innovative treatments to improve patient outcomes. The center's work in this area is characterized by its exploration of novel therapeutic agents like astegolimab, aimed at reducing the frequency and severity of COPD exacerbations.
Through rigorous clinical trials, the center contributes significantly to the understanding and management of COPD, offering hope for enhanced quality of life for patients.
Specializing in the treatment of Peripheral Neuropathic Pain (PNP), the center is dedicated to advancing pain management strategies. Research efforts are concentrated on evaluating the efficacy of NT 201 injections, providing new avenues for relief in conditions such as postherpetic neuralgia and pain following peripheral nerve injury.
The center's pioneering work in this field aims to establish superior pain reduction methods, enhancing patient comfort and functionality.
In the realm of Migraine Prevention, the center is renowned for its research on Dysport® as a preventive treatment for both chronic and episodic migraines. This research is pivotal in reducing the frequency of migraine days, thereby improving the daily lives of sufferers.
By focusing on innovative preventive strategies, the center is making significant strides in migraine management, offering new hope to those affected by this debilitating condition.
The center is a leader in the study of Post-Menopausal Osteoporosis, with a focus on the efficacy and safety of BP16. This research is crucial in demonstrating therapeutic equivalence with existing treatments, aiming to improve bone mineral density and reduce fracture risk in post-menopausal women.
Through its comprehensive research efforts, the center is advancing the understanding and treatment of osteoporosis, contributing to better health outcomes for women worldwide.
Clinical trials currently enrolling participants at this site.
Efficacy and Safety of Once‑Daily Oral ASC30 in Adults with Obesity or Overweight: A Phase III Randomized Placebo‑Controlled Trial
PolandA Phase III Study of ASC30 Sodium for Weight Loss in Adults with Obesity or Overweight and Type 2 Diabetes
PolandEffect of zenagamtide on major adverse cardiovascular events in overweight or obese adults with established atherosclerotic cardiovascular disease
PolandStudy of SPN-817 (Huperzine A) in Adults with Focal Onset Seizures: Testing Safety and Effectiveness of Treatment
PolandLong-term safety study of oral povorcitinib in patients with hidradenitis suppurativa, prurigo nodularis, or vitiligo who previously participated in clinical trials
PolandStudy of laroprovstat (AZD0780) to reduce heart attack, stroke and vascular complications in patients with atherosclerotic cardiovascular disease or high risk of developing it
PolandPolandStudy comparing aciclovir gel and cream effectiveness in treating recurrent cold sores (herpes labialis)
PolandStudy on Efruxifermin for Patients with Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH) and Fibrosis
PolandStudy on the Effectiveness of Abelacimab for High-Risk Atrial Fibrillation Patients Unsuitable for Oral Anticoagulation
PolandStudy on the Effects of BP16 and Denosumab in Women with Post-Menopausal Osteoporosis
PolandA study to evaluate the effect of CX11 trometamol monohydrate in patients with type 2 diabetes
PolandMove up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
